openPR Logo
Press release

Subcutaneous Immunoglobulin Market | Evolving Technology, Trends and industry Analysis 2024

10-26-2017 02:21 PM CET | Health & Medicine

Press release from: Transparency Market Research

Subcutaneous Immunoglobulin Market | Evolving Technology,

Key companies in The Global Subcutaneous Immunoglobulin Market include Grifols S.A., CSL Behring LLC, Shire Plc., Biotest AG, Kedrion S.p.A., Octapharma AG, Baxalta Incorporated, and Talecris Biotherapeutics, Inc. The global subcutaneous immunoglobulin market is likely to present an opportunity-filled landscape for new players in the coming years, while steady expansion efforts are likely to help existing market players consolidate their position in the subcutaneous immunoglobulin market.

According to Transparency Market Research (TMR), the global subcutaneous immunoglobulin market is expected to exhibit a robust 14% CAGR between 2016 and 2024. The market was valued at US$2.7 bn in 2015 and is expected to rise to a valuation of US$8.8 bn by 2024.

View Full Report ToC, Figures and Tables-

http://www.transparencymarketresearch.com/subcutaneous-immunoglobulin-market.html

By application, primary immunodeficiency diseases accounted for close to 70% of the global subcutaneous immunoglobulin market in 2015 and is likely to dominate the market in the coming years due to the growing prevalence of PIDDs. Geographically, North America is likely to remain the leading contributor to the global subcutaneous immunoglobulin market over the 2016-2024 forecast period due to the steady backing given to the healthcare sector in the region for consistent product improvements, which has resulted in the availability of a diverse array of products in the subcutaneous immunoglobulin market.

Request Brochure of the Report @

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20594

Steady Technological Progress Vital for Subcutaneous Immunoglobulin Market

The subcutaneous immunoglobulin market has witnessed impressive growth over the years since the launch of the medicine, and presently there has been a noticeable rise in the adoption of subcutaneous immunoglobulin in developing regions of the world. Therapeutically advanced products that have been recently introduced to the market or are currently in development address unmet needs in two key ways: Attempting to reduce the number of systemic adverse events and formulating concentrated solutions that reduce the infusion time. These new technologies will drive market growth, encouraging further innovation from the next round of startup players.

New products are being developed in the subcutaneous immunoglobulin market that aim to improve and facilitate subcutaneous administration of immunoglobulins. For instance, hyaluronidase-facilitated administration increases the bioavailability of SCIG and allows administration of large volumes at a single site. Hyquia, developed by Shire Plc., is one such formulation, supplied in a dual vial unit containing one vial of immunoglobulin infusion 10% and one vial of recombinant human hyaluronidase. The companies are producing more concentrated formulations that will reduce the volume required for administration. For instance, Cuvitru, developed by Shire Plc., is a subcutaneous immunoglobulin 20% solution, with the ability to infuse up to 60 mL (12 grams) per site per hour resulting in shorter infusion durations and fewer infusion sites compared to other conventional subcutaneous treatments. As these developments convert into clinical practice, more patients and physicians may choose the subcutaneous route for administration of immunoglobulin in future.

Request to view Sample Report -

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=20594

The growing government support to measures combating the spread of deadly diseases such as AIDS is likely to help the subcutaneous immunoglobulin market’s progress in the coming years. While primary immunodeficiency diseases are the primary target for subcutaneous immunoglobulin market players, AIDS treatment could contribute significantly to the market in the coming years. The rising demand for home care in various medical channels is also likely to help the subcutaneous immunoglobulin market, as it will allow for widespread adoption of the infrastructure needed to enable in-home administration of subcutaneous immunoglobulin on a large scale.

Subcutaneous Immunoglobulin Market Report is available @ US$ 5795

http://www.transparencymarketresearch.com/checkout.php?rep_id=20594<ype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Subcutaneous Immunoglobulin Market | Evolving Technology, Trends and industry Analysis 2024 here

News-ID: 788356 • Views:

More Releases from Transparency Market Research

Solid Tires Market Expected to Witness Impressive Growth at a 8.1% CAGR by 2031
Solid Tires Market Expected to Witness Impressive Growth at a 8.1% CAGR by 2031
The latest research study released by Transparency Market Research on "Solid Tires Market Forecast to 2023-2031 ″ research provides accurate economic, global, and country-level predictions and analyses. Solid Tires market is estimated to attain a valuation of US$ 760.0 Mn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 8.1% during
Automotive Cyber security Market Sales Estimated to Hit USD 10.5 Billion by 2031| Says Transparency Market Research
Automotive Cyber security Market Sales Estimated to Hit USD 10.5 Billion by 2031 …
The latest research study released by Transparency Market Research on "𝐀𝐮𝐭𝐨𝐦𝐨𝐭𝐢𝐯𝐞 𝐂𝐲𝐛𝐞𝐫 𝐬𝐞𝐜𝐮𝐫𝐢𝐭𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟐𝟑-𝟐𝟎𝟑𝟏 ″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Automotive Cyber security industry, as
Ready-mix Concrete Market to Witness Exponential Growth with a CAGR of 6.1% from 2022 to 2031: TMR Study
Ready-mix Concrete Market to Witness Exponential Growth with a CAGR of 6.1% from …
The latest research study released by Transparency Market Research on "𝐑𝐞𝐚𝐝𝐲-𝐦𝐢𝐱 𝐂𝐨𝐧𝐜𝐫𝐞𝐭𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟐𝟑-𝟐𝟎𝟑𝟏 ″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Ready-mix Concrete industry, as well as
Mining Automation Market to Surge at 6.4% CAGR, Hitting US$ 7.3 Bn by 2031, According to TMR Study
Mining Automation Market to Surge at 6.4% CAGR, Hitting US$ 7.3 Bn by 2031, Acco …
The latest research study released by Transparency Market Research on "𝐌𝐢𝐧𝐢𝐧𝐠 𝐀𝐮𝐭𝐨𝐦𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟐𝟑-𝟐𝟎𝟑𝟏 ″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Mining Automation industry, as well as

All 5 Releases


More Releases for Subcutaneous

Growth Opportunities in the Global Subcutaneous Biologics Market
Increase in Awareness and the number of Diagnosed cases will Drive Demand in Developing Regions In terms of geography, the global market for subcutaneous biologics is segmented into four major regions, namely, North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW). There is huge healthcare spending in countries such as United States and Canada, and high prevalence of diseases such as rheumatoid arthritis and breast cancer. The Centers for
Subcutaneous Injector Sales Market Report 2017
Subcutaneous Injector market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Browse the full report with a table of contents : https://www.reportsandmarkets.com/reports/global-subcutaneous-injector-sales-market-report-2017-1701051 Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Subcutaneous Injector for
Unmet Need Remains for Subcutaneous Sustained Release Injectables
(Amherst, NH) - As patients live longer and the prevalence and incidence of chronic ailments increase across the general population, drug developers and their delivery device partners are adapting to address what will become a significant market opportunity. Chronic conditions require drug administration over long periods of time, placing a greater emphasis on self-administration and reduced dosing frequency. With the shift away from caregiver interaction, drug safety and compliance/adherence
Global Subcutaneous Immunoglobulin Market | MarketResearchReports.biz
Latest industry research report on: Global Subcutaneous Immunoglobulin Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Global Subcutaneous Immunoglobulin Market: Overview Primary humoral immunodeficiency or primary immune deficiency diseases (PIDD) is a group of disorders in which the immune system of an individual does not function properly. In PIDD patients, the number of antibodies produced in the body is not sufficient, or the ones produced are
Subcutaneous Immunoglobulin Market Demand and Growth Upto 2024
Immunoglobulin, commonly known as an antibody, is a Y-shaped protein manufactured primarily by plasma cells. Immunoglobulin is utilized by the immune system to counterbalance pathogens. Subcutaneous injections are administered as vaccines and medications including insulin and immunoglobulin. The process of administering immunoglobulin is known as immunoglobulin therapy. When immunoglobulin therapy is applied below the dermis and epidermis, or cutis, it is known as subcutaneous immunoglobulin. Subcutaneous therapy is useful as
Subcutaneous Drug Delivery Market & Pipeline Insight
Subcutaneous sites along with intramuscular and intravenous sites are part of parenteral route of drug entry. Maximum pharmacological benefits of a drug could be achieved by deciding effective route of administration depending upon pharmacodynamic properties of the drug to be used. Subcutaneous route is commonly used for the administration of therapeutics into the body for better drug delivery of lipophilic, proteinecious, small molecule drugs. It is characterized by less vasculature,